Ask AI
ProCE Banner Activity

Evolving Standards in Metastatic Colorectal Cancer: Insights on Sequencing, Targeted Therapy, and Immunotherapy Integration

Clinical Thought

The treatment landscape for metastatic CRC is rapidly evolving. How are you incorporating new data into clinical practice?

Released: October 31, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by a grant from Pfizer Inc.

Pfizer Inc.

Disclosure

Primary Author

Zev A. Wainberg, MD: consultant/advisor/speaker: AbbVie, Alligator, Amgen, Arcus, AstraZeneca, Bayer, BeOne, Bristol Myers Squibb, Daiichi Sankyo, EMD Serono, Gilead, Ipsen, Janssen, Jazz, Lilly, Merck, Novartis, Pfizer, Phanes, Revolution Medicine.